Accurate detection of the oncogenic fusion genes ETV6-LYN [19, 20], NUP98-NSD1 [21–23], and PIM3-SCO2 [24] facilitates their recognition as genetically defined entities for AML classification. The gene discussed is NSD1; the disease is acute myeloid leukemia.